News

The top reasons Ozempic users are going to the hospital — and the ‘Wild West’ factor that could be driving an unexpected issue
Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side effects are sending some users to the ER.
Gen Z Is Leading a New Weight Loss Trend: Ozempic Microdosing
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Weight loss skincare is on the way: New antiaging treatment was designed to battle ‘Ozempic face’
You wanted a tighter waistline — and ended up with a looser face. As Ozempic and other GLP-1 weight-loss medications ...
New Weight-Loss Drugs Are Sending a Surprising Number of Americans to the Emergency Room
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
Ozempic blindness to Ozempic mouth: Beware of these shocking side effects of the weight loss drug
Ozempic and similar weight loss drugs offer significant health benefits, including reduced heart disease risk and improved ...
Everything to know about the new weight loss pill that works as well as Ozempic — and when you can get it
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Healthify shifts gears to incorporate weight-loss drugs, cash in on anti-obesity boom
Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...
This new pill may replace weight-loss injections like Ozempic
A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...
Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions
Major drug manufacturers have already spent over $3 million lobbying the government to clamp down on copycat versions of ...